DESKAPD MEDICINĂ INTERNĂ

(1) https://jamanetwork.com/journals/jama/fullarticle/1151505

(2) https://scihub.ru/https://doi.org/10.1016/j.vaccine.2013.11.053

(3) Kvasnicka F, Bíba B, Sevcík R, Voldrich M, Krátká J. Analysis of the active components of silymarin. J Chromatogr A. 2003;990:239–245.

(4) Trouillas P, Marsal P, Svobodová A, Vostálová J, Gazák R, Hrbác J, Sedmera P, Kren V, Lazzaroni R, Duroux JL, et al. Mechanism of the antioxidant action of silybin and 2,3-dehydrosilybin flavonolignans: a joint experimental and theoretical study. J Phys Chem A. 2008;112:1054–1063.

(5) Nomura M, Takahashi T, Nagata N, Tsutsumi K, Kobayashi S, Akiba T, Yokogawa K, Moritani S, Miyamoto K. Inhibitory mechanisms of flavonoids on insulin-stimulated glucose uptake in MC3T3-G2/PA6 adipose cells. Biol Pharm Bull. 2008;31:1403–1409.

(6) Detaille D, Sanchez C, Sanz N, Lopez-Novoa JM, Leverve X, El-Mir MY. Interrelation between the inhibition of glycolytic flux by silibinin and the lowering of mitochondrial ROS production in perifused rat hepatocytes. Life Sci. 2008;82:1070–1076.

(7) https://pubmed.ncbi.nlm.nih.gov/17487930/
(8) https://www.mdpi.com/1420-3049/24/11/2046/htm
(9) https://www.sciencedirect.com/science/article/pii/B9780702055140000300